Back to ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

RLAYRLAY
2 quarters

Position history for ARROWSTREET CAPITAL, LIMITED PARTNERSHIPARROWSTREET CAPITAL, LIMITED PARTNERSHIP's holdings in RELAY THERAPEUTICS INC

Yes. Arrowstreet Capital holds 2,238,929 shares of RLAY (Relay Therapeutics), worth $41.9M, as of its Q2 2026 13F filing. It increased the position from 668,289 shares in Q1 2026. Arrowstreet Capital has held RLAY since Q1 2026, across 2 quarterly 13F filings.

Current Value

$41.9M

Current Shares

2.2M

Total Value Change

+$35.2M

Total Shares Change

+1.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.2M
+235.0%
$41.9M0.0%$18.71
47
2026-Q1
New
668,289
-
$6.6M0.0%$9.85
38

Other major holders of RLAY: SB INVESTMENT ADVISERS (UK) LTD

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used